Stearoyl-CoA desaturase inhibition is toxic to acute myeloid leukemia displaying high levels of the de novo fatty acid biosynthesis and desaturation
Vilma Dembitz(University of Zagreb), Paolo Gallipoli(Wellcome/MRC Cambridge Stem Cell Institute), Jérôme Tamburini(Centre National de la Recherche Scientifique), Mariia Yuneva(The Francis Crick Institute), Keith Woodley(Bank of England), Jan Jacob Schuringa(University Medical Center Groningen), Findlay Bewicke‐Copley(Queen Mary University of London), Andrew J. Finch(Queen Mary University of London), Juerg Schwaller(University Hospital of Basel), Emeline Boët(Centre National de la Recherche Scientifique), Lydia M. Wang(Institute of Cancer Research), Pedro R. Cutillas(Consejo Superior de Investigaciones Científicas), Richard Burt(The Francis Crick Institute), Alex von Kriegsheim(Edinburgh Cancer Research), Jozef Durko(Queen Mary University of London), Hannah Lawson(University of London), Ana Rio‐Machín(Queen Mary University of London), Jean‐Emmanuel Sarry(Inserm), Lori Hazlehurst(West Virginia University), Kamil R. Kranc(Queen Mary University of London), Sirisha Natani(Queen Mary University of London), Joana Campos(Queen Mary University of London), Lieve Oudejans(University Medical Center Groningen), Pedro Casado(Queen Mary University of London), Bela Patel(Queen Mary University of London), Diego A. Pereira‐Martins(Universidade Federal de Pernambuco), Aoife M. S. Magee(Queen Mary University of London), Céline Philippe(Centre National de la Recherche Scientifique), Kevin Rouault‐Pierre(Queen Mary University of London), Jude Fitzgibbon(Queen Mary University of London), Barrie Peck(Cancer Research Center), Giovanny Rodriguez Blanco(Edinburgh College), Samantha Atkinson(The Francis Crick Institute), Sophie C. James(Queen Mary University of London), John A. Copland(Jacksonville College), Michael J. Austin(Queen Mary University of London)
Cited by 21
Related Papers
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia
|Cell Reports|2016|834
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
|Cancer Cell|2013|571
Targeting the RNA m6A Reader YTHDF2 Selectively Compromises Cancer Stem Cells in Acute Myeloid Leukemia
|Cell stem cell|2019|552
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
|Endocrine Related Cancer|2008|395